Tenaya Therapeutics has appointed Tim Hoey chief scientific officer of the South San Francisco, CA, biotech. Before joining Tenaya, Hoey was senior vice president of cancer biology and co-chief scientific officer of Redwood City, CA-based OncoMed (NASDAQ: OMED). Tenaya spun out of the Gladstone Institutes last year backed by a $50 million Series A investment […]
Original Article: OncoMed’s Tim Hoey Joins Tenaya Tx as Chief Scientific Officer
NEXT ARTICLE